Nuveen’s Diebold Nixdorf Incorporated DBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-29,302
Closed -$42K 3152
2022
Q4
$42K Hold
29,302
﹤0.01% 3140
2022
Q3
$71K Hold
29,302
﹤0.01% 3164
2022
Q2
$67K Sell
29,302
-705,548
-96% -$2.63M ﹤0.01% 3202
2022
Q1
$5.22M Buy
734,850
+65,770
+10% +$562K ﹤0.01% 2038
2021
Q4
$6.05M Sell
669,080
-167,193
-20% -$1.55M ﹤0.01% 2013
2021
Q3
$8.46M Sell
836,273
-49,227
-6% -$540K ﹤0.01% 1896
2021
Q2
$11.4M Sell
885,500
-102,999
-10% -$1.41M ﹤0.01% 1791
2021
Q1
$14M Sell
988,499
-131,163
-12% -$1.81M ﹤0.01% 1581
2020
Q4
$11.9M Buy
1,119,662
+122,735
+12% +$1.11M ﹤0.01% 1588
2020
Q3
$7.62M Buy
996,927
+558,683
+127% +$4.11M ﹤0.01% 1683
2020
Q2
$2.66M Sell
438,244
-58,886
-12% -$291K ﹤0.01% 2219
2020
Q1
$1.75M Sell
497,130
-170,618
-26% -$1.44M ﹤0.01% 2254
2019
Q4
$7.05M Sell
667,748
-46,383
-6% -$412K ﹤0.01% 1802
2019
Q3
$8M Buy
714,131
+389,576
+120% +$4.61M ﹤0.01% 1698
2019
Q2
$2.97M Buy
+324,555
New +$3.39M ﹤0.01% 2248
2017
Q2
Sell
-25,640
Closed -$787K 1351
2017
Q1
$787K Sell
25,640
-5,349
-17% -$151K ﹤0.01% 1042
2016
Q4
$779K Buy
30,989
+434
+1% +$10.2K ﹤0.01% 1227
2016
Q3
$757K Buy
30,555
+510
+2% +$13.5K ﹤0.01% 1151
2016
Q2
$746K Sell
30,045
-440
-1% -$11.3K ﹤0.01% 1107
2016
Q1
$881 Sell
30,485
-218
-0.7% -$5.7K ﹤0.01% 1064
2015
Q4
$924 Sell
30,703
-186
-0.6% -$6.32K ﹤0.01% 1096
2015
Q3
$920 Hold
30,889
0.01% 1124
2015
Q2
$1.08K Buy
30,889
+4,614
+18% +$163K 0.01% 1126
2015
Q1
$932K Hold
26,275
0.01% 1192
2014
Q4
$910K Hold
26,275
0.01% 1213
2014
Q3
$928K Buy
26,275
+1,389
+6% +$52.4K 0.01% 1174
2014
Q2
$1M Hold
24,886
0.01% 1176
2014
Q1
$993K Hold
24,886
0.01% 1146
2013
Q4
$821K Hold
24,886
0.01% 1176
2013
Q3
$731K Buy
24,886
+1,599
+7% +$50.1K ﹤0.01% 1227
2013
Q2
$785K Buy
+23,287
New +$721K 0.01% 1147

Other funds holding DBD

Nuveen's DBD Position: Q1 2023 in Review

Nuveen sold out of Diebold Nixdorf Incorporated (DBD) in Q1 2023, closing a stake of 29,302 shares — an estimated $42K sold.

Nuveen first reported a position in DBD in Q2 2013 and held it in 31 quarters. The position peaked at $14M in Q1 2021. 128 funds tracked by Wall St. Rank hold DBD as of Q1 2023.

  • Nuveen reported no remaining Diebold Nixdorf Incorporated position as of Q1 2023 after selling out during the quarter.
  • Nuveen sold 29,302 Diebold Nixdorf Incorporated shares in Q1 2023, an estimated $42K.
  • Nuveen first reported a position in Diebold Nixdorf Incorporated in Q2 2013 and held it in 31 quarters.
  • Nuveen's Diebold Nixdorf Incorporated position peaked at $14M in Q1 2021.
  • 128 funds tracked by Wall St. Rank held Diebold Nixdorf Incorporated as of Q1 2023.

Based on Nuveen's 13F filing for Q1 2023, filed 15 May 2023.